The closing price of CARGO Therapeutics Inc (NASDAQ: CRGX) was $22.32 for the day, down -0.40% from the previous closing price of $22.41. In other words, the price has decreased by -$0.09 from its previous closing price. On the day, 236308 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our analysis of CRGX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 19.35 and its Current Ratio is at 19.35. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on December 05, 2023, initiated with a Buy rating and assigned the stock a target price of $34.
On December 05, 2023, JP Morgan started tracking the stock assigning a Overweight rating and target price of $23.JP Morgan initiated its Overweight rating on December 05, 2023, with a $23 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 14 ’23 when Third Rock Ventures V, L.P. bought 1,333,333 shares for $15.00 per share. The transaction valued at 19,999,995 led to the insider holds 1,807,119 shares of the business.
PERCEPTIVE ADVISORS LLC bought 666,666 shares of CRGX for $9,999,990 on Nov 14 ’23. The Former 10% Owner now owns 2,912,835 shares after completing the transaction at $15.00 per share. On Nov 14 ’23, another insider, Samsara BioCapital GP, LLC, who serves as the 10% Owner of the company, bought 666,666 shares for $15.00 each. As a result, the insider paid 9,999,990 and bolstered with 4,121,689 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRGX now has a Market Capitalization of 882.13M and an Enterprise Value of 504.93M.
Stock Price History:
Over the past 52 weeks, CRGX has reached a high of $33.92, while it has fallen to a 52-week low of $13.14. The 50-Day Moving Average of the stock is 24.39, while the 200-Day Moving Average is calculated to be 21.41.
Shares Statistics:
CRGX traded an average of 299.88K shares per day over the past three months and 738.46k shares per day over the past ten days. A total of 41.21M shares are outstanding, with a floating share count of 26.34M. Insiders hold about 33.09% of the company’s shares, while institutions hold 66.42% stake in the company. Shares short for CRGX as of Mar 15, 2024 were 2.19M with a Short Ratio of 7.35, compared to 1.8M on Feb 15, 2024.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. The consensus estimate for the next quarter is -$1.27, with high estimates of -$1 and low estimates of -$1.46.
Analysts are recommending an EPS of between -$4.2 and -$6.22 for the fiscal current year, implying an average EPS of -$5.5. EPS for the following year is -$4.84, with 2 analysts recommending between -$4.3 and -$5.39.
